
    
      The preset registry aim is to evaluate the safety and efficacy of paclitaxel-releasing
      SeQuentÂ® Please Neo balloon in the following scenarios: restenosis, bifurcation lesions,
      small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The principal
      objective is to determine the success of the procedure and the preservation of vascular
      permeability.
    
  